Clinical Trial

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Study acronym: DCB-MVD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 27, 2023 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, multicenter, open-label, observational study to investigate the impact of using drug-coated balloons (DCBs) in the treatment of coronary artery lesions in patients with multivessel coronary artery disease (MVD), as opposed to the default strategy of using only drug-eluting stents (DES). The investigators aim to assess changes in clinical practice towards a hybrid treatment strategy (DES and DCB) and its effects on clinical outcomes.
Trial Details
NCT Number NCT06104033
Lead Sponsor Bon-Kwon Koo
Collaborators: Seoul National University Hospital, St Vincent's Hospital, Uijeongbu St. Mary Hospital, Gachon University Gil Medical Center, Gangnam Severance Hospital, Kyunghee University Medical Center, Keimyung University Dongsan Medical Center, Inje University Ilsan Paik Hospital, Daegu Catholic University Medical Center, Sejong General Hospital, Seoul National University Bundang Hospital, Soonchunhyang University Hospital, Yeungnam University Hospital, Wonju Severance Christian Hospital, Ulsan University Hospital, Ewha Womans University Mokdong Hospital, Inje University, Chonnam National University Hospital, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University Hospital, Ulsan Medical Center, Hanyang University Seoul Hospital, Jeju National University Hospital, KangWon National University Hospital, Uijeongbu Eulji University Hospital, Seoul St. Mary's Hospital, Gyeongsang National University Hospital, Severance Hospital, Chosun University Hospital, Kyungpook National University Hospital, Korea University Anam Hospital, Kyung Hee University Hospital at Gangdong, Ajou University School of Medicine
Conditions Coronary Artery Disease, Multi Vessel Coronary Artery Disease
Enrollment 500 participants
Start Date 2023-09-18
Primary Completion 2025-08-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2023-10-27